Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities

Cancers(2022)10.3390/cancers14051322Source: DataRank Database

Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.36)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Amber Wolfe,Krishna Kumar Ramajayam ORCID,Sanket Pattanaik,Thomas Z. Benton ORCID,Yuri K. Peterson ORCID

Live enrichment

PubMed:35267630 PMC:PMC8909191 OpenAlex:https://openalex.org/W4220686098

National Institutes of Health

Grant: R21CA249690

National Institutes of Health

Grant: RO1CA181664

National Institutes of Health

Grant: C06 RR015455

National Institutes of Health

Grant: C06 RR018823

National Institutes of Health

Grant: UL1TR001450

FWCI

0.36

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/14/5/1322/pdf?version=1646386511

publisherhttps://www.mdpi.com/2072-6694/14/5/1322/pdf?version=1646386511

publisherhttps://www.mdpi.com/2072-6694/14/5/1322/pdf

journalhttps://doi.org/10.3390/cancers14051322

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35267630

Fields of Study

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRadiation Therapy and Dosimetry

Keywords

HyperthermiaPharmacokineticsDoxorubicinPharmacologyDrug deliveryMedicineJugular veinDrugExtracorporeal circulationDistribution (mathematics)ChemistryChemotherapySurgeryInternal medicineThermosensitive Liposomes

Sustainable Development Goals

SDG 0: Good health and well-being